SOPHiA GENETICS (SOPH) Change in Receivables (2020 - 2025)

SOPHiA GENETICS has disclosed Change in Receivables across 6 years of filings, most recently posting -$6.6 million for Q4 2025.

• Change in Receivables for Q4 2025 came in at -$6.6 million, down 419.1% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.6 million (down 212.07% YoY), and the FY2025 annual result was -$6.6 million, down 212.07% from the prior year.
• Change in Receivables came in at -$6.6 million for Q4 2025 at SOPHiA GENETICS, down from $1.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $3.0 million in Q4 2021 to a low of -$6.6 million in Q4 2025.
• The 5-year median for Change in Receivables is $180000.0 (2021), against an average of -$203650.0.
• Across the five-year window, Change in Receivables surged 478.37% in 2021 and slumped 158350.0% in 2023, its largest moves.
• SOPHiA GENETICS's Change in Receivables stood at $3.0 million in 2021, then plunged by 31.91% to $2.0 million in 2022, then plunged by 278.77% to -$3.6 million in 2023, then jumped by 157.43% to $2.1 million in 2024, then slumped by 419.1% to -$6.6 million in 2025.
• The last three Change in Receivables figures came in at -$6.6 million (Q4 2025), $1.3 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.